Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 30, 2026
4 Sep 18, 2026 4
S-3ASR Sep 18, 2026 S-3ASR
144 Sep 17, 2026
4 Sep 3, 2026 4
144 Sep 1, 2026
4 Aug 19, 2026 4
4 Aug 14, 2026 4
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 13, 2026
4 Aug 11, 2026 4
4 Aug 11, 2026 4
4 Aug 11, 2026 4
144 Aug 10, 2026
144 Aug 10, 2026
144 Aug 10, 2026
4 Aug 7, 2026 4
144 Aug 7, 2026
144 Aug 7, 2026
144 Aug 7, 2026
SCHEDULE 13G/A Aug 7, 2026
SCHEDULE 13G Aug 7, 2026
10-Q Aug 4, 2026 10-Q
8-K Aug 4, 2026 8-K
SCHEDULE 13G/A Jul 28, 2026
← Newer Page 1 of 27 · 656 filings Older →